CVRx to Present at the William Blair 42nd Annual Growth Stock Conference
May 23, 2022 16:30 ET
|
CVRx, Inc.
MINNEAPOLIS, May 23, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System
May 09, 2022 08:30 ET
|
CVRx, Inc.
Heart failure patients implanted with Barostim can now receive conditional MRI scans MINNEAPOLIS, May 09, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), developer of the world’s...
CVRx Reports First Quarter 2022 Financial and Operating Results
April 25, 2022 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, April 25, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx to Report First Quarter 2022 Financial and Operating Results and Host Conference Call
April 12, 2022 16:30 ET
|
CVRx, Inc.
MINNEAPOLIS, April 12, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
February 15, 2022 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Feb. 15, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 15, 2022
February 01, 2022 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Feb. 01, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results
January 10, 2022 08:00 ET
|
CVRx, Inc.
MINNEAPOLIS, Jan. 10, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 21, 2021 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Dec. 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 16, 2021 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Nov. 16, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally...
CVRx Reports Third Quarter 2021 Financial and Operating Results
November 04, 2021 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Nov. 04, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and...